Revenue in the medical devices segment worldwide 2016-2030

Revenue in the medical devices segment worldwide from 2016 to 2030

Revenue in the medical devices segment worldwide is projected to reach about 572 billion dollars in 2026, up from about 368 billion in 2016. The segment is forecast to grow at about 5.8 percent a year to reach roughly 717 billion dollars by 2030. That makes the medical device industry the largest single block of medical technology, and one of the biggest sectors in healthcare after pharmaceuticals. Medical devices are the hardware of modern medicine, the pacemakers, scanners, implants and surgical tools without which almost no serious treatment happens, and the market behind them has grown into the largest single block of the medical technology industry. On the 2026 figures, medical devices at about 572 billion dollars make up roughly 86 percent of the 666 billion dollar medical technology market, with in vitro diagnostics accounting for the remaining 94 billion. What makes the medical devices series worth studying closely is not any single year but the shape of the whole, a segment that has grown by more than half in a decade without a single dramatic year, the very opposite of the technology markets it is often grouped with.

Medical devices are the larger half of the medical technology market, accounting for about 86 percent of it. The figures sit within our medical technology market by segment and medical technology industry coverage.

From 368 to 717 billion: medical devices revenue grew from about 368 billion dollars in 2016 to a projected 572 billion in 2026 and a forecast 717 billion by 2030, stalling only in 2020.

Cardiology devices are the largest category, worth about 84 billion dollars in 2026, and the United States is the largest market at about 212 billion, themes our medtech industry data and US GDP coverage explores.

A note on the data. The figures show revenue in the medical devices segment worldwide from 2016 to 2030, in billion dollars, from Statista Market Insights. Medical devices exclude in vitro diagnostics, and years from 2026 are forecasts. Because the figures are modeled estimates at manufacturer price level and different research firms draw the boundaries of the segment differently, medical devices market size estimates vary widely between sources, from roughly 570 billion dollars to over 620 billion. The medical devices market covers a broad range of products marketed into medical specialties or types of application, including cardiology, diagnostic imaging, orthopedics, ophthalmics, general and plastic surgery, endoscopy, diabetes care, dental and drug delivery devices.

Medical Devices Revenue Worldwide

The table shows revenue in the medical devices segment worldwide by year. It shows steady growth from about 368 billion dollars in 2016 to a forecast 717 billion by 2030, with only the pandemic year of 2020 breaking the pattern. Reading down the table shows a segment that has added roughly 204 billion dollars of annual revenue in a decade and is forecast to add a further 145 billion in the four years to 2030. Because the figures use current exchange rates and modeled estimates, the totals are best read as a consistent series showing the shape and pace of growth rather than as precise absolute values for any single year. The single most revealing figure in the table is the growth rate column, which shows the segment barely moving in 2020 and then jumping sharply in 2021, the clearest possible illustration of postponed rather than lost demand.

What Counts as a Medical Device?

The medical devices segment covers the instruments and machines used to prevent, diagnose and treat disease, from pacemakers and joint implants to imaging systems and surgical tools. It excludes in vitro diagnostics, which are counted separately. A medical device, in short, is any instrument or machine used on or in the body for a medical purpose, which is what separates the medical products industry from pharmaceuticals, where the product is a molecule rather than a machine. Getting the definition right matters more here than in most markets, because medical devices are routinely confused with the wider medical technology industry, with healthcare equipment generally, and with consumer health gadgets that fall entirely outside the count. The boundaries of the segment are drawn tightly on purpose, capturing the machines and instruments themselves rather than the treatments delivered with them or the drugs given alongside them, which keeps the series comparable across countries and years.

The definition matters because medical devices and diagnostics behave very differently, with devices tied to procedures and implants rather than testing volumes, a distinction our medtech market and global pharmaceutical industry coverage frames.

Also excluded are pharmaceuticals, treatment services and consumer technologies such as fitness trackers, so the figures capture the medical hardware itself rather than the wider healthcare economy around it. The exclusion of consumer technologies is particularly worth noting, since smartwatches and fitness trackers, however health-related their features, are counted in consumer electronics rather than in the medical devices market. The line between a medical device and a consumer health product is becoming harder to draw as smartwatches gain regulatory clearance for features such as heart rhythm detection, which sit in a grey zone between the two markets.

How Fast Has the Segment Grown?

Medical devices revenue has grown every year of the past decade apart from a pandemic slowdown. Revenue rose from about 368 billion dollars in 2016 to about 572 billion in 2026, an increase of roughly 55 percent, or about 4.5 percent a year on average. Few sectors of comparable size have grown as consistently, which is why the medical devices industry is often described as defensive rather than cyclical. The consistency of growth in medical devices is its most commercially valuable feature, letting manufacturers plan capacity and health systems budget with a confidence that few other industries allow. Revenue rose from about 368 billion dollars in 2016 to about 430 billion in 2020, about 522 billion in 2024 and about 572 billion in 2026, a compound annual growth rate of roughly 4.5 percent over the decade. The reliability of device demand rests on something no marketing department can manufacture, namely the fact that hips wear out, hearts fail and eyes cloud over on a schedule set by biology rather than by the business cycle.

The steady growth reflects ageing populations, rising chronic disease and the spread of advanced devices into new markets, drivers our US population coverage frames.

Creeping upward: medical devices make up about 86 percent of the medical technology market in 2026, up from about 85 percent a decade earlier, dipping only during the testing boom.

Growth stalled in 2020, when elective operations were postponed and device sales barely moved, then rebounded sharply in 2021 as backlogs of postponed procedures were cleared. The recovery from 2020 was rapid and complete, and by 2022 the segment had returned to the level its pre-pandemic trend would have predicted, suggesting the disruption postponed procedures rather than destroying demand. Looking across the whole series, the segment has proved remarkably resilient, absorbing a global pandemic with barely a pause in its long climb and returning quickly to its underlying trend. Looking across the whole series, the segment has proved remarkably resilient, absorbing a global pandemic with barely a pause in its long climb and returning quickly to its underlying trend.

What Is the Largest Device Category?

Cardiology devices are the largest category within medical devices, worth about 84 billion dollars in 2026. Orthopedic devices, general and plastic surgery devices, ophthalmic devices and diabetes care devices follow, each worth between about 50 and 75 billion. The internal structure of the medical devices segment is unusually flat, with no single category dominating, and that breadth is precisely what has made the segment so resilient through economic cycles and even a global pandemic. Cardiology devices about 84 billion dollars lead the segment in 2026, ahead of orthopedic devices on about 74 billion, general and plastic surgery devices on about 64 billion, ophthalmic devices on about 58 billion and diabetes care devices on about 54 billion. The category structure of medical devices repays close attention, because it explains why the largest device makers are diversified conglomerates rather than specialists, since no single category is large enough on its own to build a giant around.

The leading position of cardiology reflects the global burden of heart disease and the high value of pacemakers, stents and heart valves, a market our biggest companies by market value coverage frames through the companies that make them.

Cardiology leads: cardiology devices are the largest category at about 84 billion dollars in 2026, ahead of orthopedics on about 74 billion and general surgery on about 64 billion.

The categories are unusually evenly matched, with no single one accounting for even a sixth of the segment, which is one reason medical devices revenue has proved so steady over time. The evenness of the category structure is the opposite of what is seen in pharmaceuticals, where a single drug class can account for a vast share of revenue, and it is one reason device makers tend to be diversified conglomerates. Looking ahead, cardiology and orthopedics are expected to contribute the most growth in absolute terms, while robotics and AI-enabled products grow fastest in percentage terms from far smaller bases. Looking ahead, cardiology and orthopedics are expected to contribute the most growth in absolute terms, while robotics and AI-enabled products grow fastest in percentage terms from far smaller bases.

The Category Split

Medical devices make up about 86 percent of the medical technology market in 2026, worth about 572 billion dollars of the roughly 666 billion total. That share has crept up over the past decade and is forecast to rise a little further by 2030. The share of medical technology accounted for by devices is one of the more stable structural facts in healthcare, and its slow drift upward is a quiet but meaningful shift in the balance of the industry. Medical devices about 572 billion dollars of a roughly 666 billion dollar medical technology market give a share of about 86 percent in 2026, forecast to reach about 87 percent by 2030. The share of medical technology accounted for by devices is one of the more stable structural facts in healthcare, and its slow drift upward is a quiet but meaningful shift in the balance of the industry.

The rising share reflects the faster growth of devices than diagnostics, especially since the pandemic testing surge unwound, a shift our chemical industry coverage frames through the reagents behind the tests.

An even spread: no single category accounts for even a sixth of the medical devices segment, with cardiology the largest at about 15 percent.

The share dipped briefly in 2021 and 2022, when diagnostics revenue surged as testing boomed, then recovered as testing volumes returned to more normal levels. The brief dip in the device share during the testing boom, and its equally brisk recovery, is one of the clearest illustrations of how temporary the pandemic distortion turned out to be.

How Big Is Diagnostic Imaging?

Diagnostic imaging devices generated about 49 billion dollars in 2025 and about 51 billion in 2026, growing at roughly 4 percent a year. The category covers MRI, CT, X-ray, ultrasound and PET systems and is smaller than often assumed. Diagnostic imaging occupies an outsized place in public perception of medical technology relative to its actual share of revenue, a gap worth understanding for anyone trying to size the market accurately. Diagnostic imaging devices generated about 49 billion dollars in 2025, a rise of about 3.9 percent on the year, and are projected at about 51 billion in 2026, or roughly 9 percent of the medical devices segment. The size of the diagnostic imaging market is one of the most commonly misstated figures in medical technology, routinely inflated in commentary that conflates the scanners themselves with the imaging services performed on them.

The modest size of imaging reflects the fact that scanners are durable capital equipment bought once a decade rather than consumables, even though each machine costs millions, a dynamic our Nasdaq stock market coverage frames.

Smaller than assumed: diagnostic imaging devices generated about 49 billion dollars in 2025 and about 51 billion in 2026, roughly 9 percent of the medical devices segment.

Imaging is the category being reshaped fastest by artificial intelligence, as algorithms take on more of the reading of scans, though the revenue effect so far has been to add software value rather than to expand hardware sales. The imaging giants have responded to artificial intelligence by buying and building algorithm portfolios of their own, so the technology that might have disrupted them is instead becoming another feature of their systems. For anyone sizing the market, the lesson is that imaging matters far more to the practice of medicine than its revenue share suggests, since a single scanner supports thousands of diagnoses a year across many specialties.

How Fast Will Devices Grow?

Medical devices are forecast to grow at about 5.8 percent a year between 2026 and 2030, faster than the medical technology market as a whole at about 5.5 percent and much faster than in vitro diagnostics at about 3.8 percent. The growth rate of medical devices is the single most important number in any medical technology forecast, because the segment is large enough that its trajectory effectively sets the trajectory of the whole industry. Medical devices are forecast to grow at about 5.8 percent a year from 2026 to 2030, against about 5.5 percent for the medical technology market as a whole and about 3.8 percent for in vitro diagnostics. A growth rate of a little under six percent sounds unremarkable until it is compounded, at which point it means the segment adds the equivalent of a mid-sized industry every four years without any change in strategy or technology.

The faster growth reflects strong demand for implants, imaging and surgical equipment as populations age, a rate our big tech revenue coverage sets against far faster technology markets.

Devices grow fastest: medical devices are forecast to grow at about 5.8 percent a year to 2030, against 5.5 percent for medtech as a whole and 3.8 percent for diagnostics.

At that rate the segment adds about 145 billion dollars of annual revenue between 2026 and 2030, accounting for more than 90 percent of the growth of the whole medical technology market. That devices supply more than nine tenths of the growth of the whole medical technology market to 2030 means the outlook for medtech is essentially the outlook for surgery, implants and imaging.

Which Country Is the Largest Market?

The United States is the largest medical devices market in the world, generating about 212 billion dollars in 2026, roughly 37 percent of the global total. China, Germany and Japan follow, though each is far behind. Where medical device revenue is earned says as much about healthcare systems as about the industry, since the countries that spend most per person on health are also where the newest devices reach patients first. The United States about 212 billion dollars in 2026 is followed at a distance by China, Germany and Japan, with the United States alone accounting for roughly 37 percent of global medical device revenue. The geographic concentration of medical device revenue is one of the least discussed facts about the industry and one of the most consequential for questions of access and equity in global health.

The American lead reflects high healthcare spending and the largest hospital market in the world by value, a pattern our global stock markets by country coverage frames.

The US leads: the United States generates about 212 billion dollars of medical device revenue in 2026, roughly 37 percent of the global total.

Outside the United States, the established centres are Western Europe and Japan, while China is the fastest-growing large market and is expected to account for a much larger share of device revenue by the end of the decade. The concentration of revenue in a handful of wealthy countries is one of the enduring features of medical devices, and one reason access to the newest implants and scanners remains so uneven around the world. The concentration of revenue in a handful of wealthy countries is one of the enduring features of medical devices, and one reason access to the newest implants and scanners remains so uneven around the world.

The Largest Device Companies

Medtronic is the largest medical device company in the world, with revenue above 33 billion dollars. Johnson & Johnson MedTech and Abbott follow, and all three are based in the United States, as are most of the largest device makers. The league table of the largest device makers is remarkably stable, dominated by a handful of American giants whose scale, distribution and regulatory experience make them very hard for newcomers to displace. The stability of the company rankings is itself telling, since in most technology industries a decade brings new leaders, while in medical devices the same names have held the top places for a generation.

The dominance of American companies reflects the depth of the US healthcare market and its research base, a pattern our AI market size coverage now touches as device makers race to add algorithms to their products.

Medtronic leads: Medtronic is the largest medical device company with revenue above 33 billion dollars, ahead of Johnson & Johnson MedTech and Abbott.

European companies retain a strong position in the highest-value hospital equipment, with Siemens Healthineers and Philips among the largest device makers, especially in imaging and patient monitoring. Taken together, the largest firms give the medical device sector an unusually stable competitive structure, with the same names holding the leading places year after year. The persistence of Siemens Healthineers and Philips near the top of the device rankings shows that while America dominates the segment overall, Europe retains a commanding position in the highest-value hospital equipment. Beyond the top ten, the device industry has a long tail of specialists, many of them highly profitable in narrow niches, and it is from this tail that the largest companies buy most of their new technology.

The Outlook to 2030

The medical devices segment is forecast to grow from about 572 billion dollars in 2026 to about 717 billion by 2030, an increase of about 145 billion. Every major category is expected to grow, with cardiology and orthopedics contributing the most in absolute terms. Forecasts for medical devices are more credible than most technology forecasts, because the demand comes from demography, and the number of people who will be over seventy in 2030 is already known with considerable precision. The segment grows from about 572 billion dollars in 2026 to about 717 billion by 2030, an increase of about 145 billion, or roughly 25 percent over four years. The forecast for medical devices is in effect the forecast for medical technology as a whole, since the segment is large enough and growing fast enough that its trajectory sets the trajectory of the entire industry.

The forecast rests on demographic certainties rather than technological bets, which makes it more reliable than most technology forecasts, a contrast our crypto market coverage draws against far more volatile markets.

Every category grows: from 2026 to 2030 every major device category expands, with cardiology rising from about 84 to about 106 billion dollars.

Cardiology adds most: of the roughly 145 billion dollars of growth to 2030, cardiology contributes about 22 billion and orthopedics about 19 billion.

The main upside risk lies in robotics and artificial intelligence, where faster than expected adoption could lift growth above the assumed rate, particularly in surgery and imaging. The main trends in the medical devices industry all point the same way, toward more software, more automation and more care delivered outside the hospital, and each of those medical device industry trends supports rather than threatens the growth of the segment. The main downside risk is pricing, since health systems under budget pressure increasingly negotiate hard on device prices, which could shave growth even as procedure volumes keep rising.

Medical Devices Revenue in Numbers

A few numbers capture the segment. Medical devices revenue is about 572 billion dollars in 2026, up from 368 billion in 2016, cardiology is the largest category at about 84 billion, and the United States is the largest market at about 212 billion. These figures together map a segment that is large, steadily growing, broad across many evenly matched categories and geographically concentrated in a handful of wealthy countries. Read as a whole, the series describes a segment whose growth is slow by technology standards and fast by industrial ones, and whose reliability is precisely what makes it valuable to plan around.

The figures matter because medical devices are the engine of the whole medical technology market, and their growth tracks both demographic change and technological progress, a link our artificial intelligence statistics coverage touches.

Together these figures show a segment that has grown steadily for a decade, is broad across many evenly matched categories, and is forecast to keep growing at about 5.8 percent a year through the end of the decade. For now, revenue in the medical devices segment stands as one of the steadiest series in global industry, a quiet but relentless climb underpinned by demographics rather than fashion.

Medical Devices: The Big Picture

Taken together, revenue in the medical devices segment from 2016 to 2030 maps a market growing steadily from 368 billion dollars to a forecast 717 billion, a story our cloud market coverage sets against faster-growing technology sectors.

Whether growth accelerates will depend on how quickly robotics and artificial intelligence move from promise to routine practice, but for now the segment climbs at a steady and highly predictable pace, alongside the hardware markets in our VR headset market overview.

Frequently Asked Questions: Medical Devices Revenue